Form 4: ResMed Director Desney Tan Acquires Shares Through Restricted Stock Units

ResMed director Desney Tan acquired 1,083 shares of common stock through the vesting of restricted stock units.

Summary

• Director Desney Tan of ResMed Inc. acquired 1,083 shares of common stock on November 20, 2024.
• The shares were acquired through the vesting of restricted stock units (RSUs).
• The RSUs will cliff vest on the earlier of November 11, 2025, or the annual shareholder's meeting in the year following the grant date.
• Following the transaction, Mr. Tan directly owns 4,929 shares of ResMed common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to positively. The acquisition of shares by a director can be seen as a positive sign of confidence in the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as part of executive compensation is a common practice among publicly traded companies, including those in the medical device industry.
• Companies like Medtronic and Stryker also use RSUs as part of their compensation packages.
• The vesting schedule of the RSUs is also typical, with a cliff vesting period followed by a full vesting.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.

Key Dates

Keywords

ResMed, Director, Desney Tan, Restricted Stock Units, RSU, Share Acquisition, Beneficial Ownership, SEC Form 4